This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Regenxbio says it is to delay dosing of patients in its DMD gene therapy clinical trial following a quality issue at an unnamed third-party contractmanufacturer.
Eli Lilly’s Biologic License Application for its monoclonal antibody lebrikizumab was denied by the regulator after issues were found at a third-party contractmanufacturing organization.
Torbay Pharmaceuticals is a sterile injectable contractmanufacturer and licence holder based in Devon, UK. We spoke with CEO Emma Rooth about the company's heritage and how it is striving to support the U.S.
Lipidor has already cooperated with the contractmanufacturer Aurena Laboratories regarding hand and skin disinfection sprays and veterinary care products. This disclosure contains information that Lipidor is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014).
As capital project delivery ramps back up to pre-pandemic levels over the coming months and years, the smaller biopharma players are looking outside their own resources for strategic manufacturing and research support, confirms a new market outlook from CRB.
Pfizer (New York, New York) and Moderna’s (Cambridge, Massachusetts) Omicron-specific Covid-19 vaccines are in late-stage development, have demonstrated good efficacy against the variant and will likely be available to the public later this year to provide an additional booster and increase demand for injectable manufacturing.
In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans.
Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. The company also offers contractmanufacturing and laboratory services.
Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. The company also offers contractmanufacturing and laboratory services.
There are three US-based companies with a manufacturing presence in Brazil: Catalent (Somerset, New Jersey), Thermo Fisher Scientific’s (Waltham, Massachusetts) subsidiary Patheon (Durham, North Carolina), and Merieux NutriSciences (Chicago, Illinois), all contractmanufacturing organisations (CMOs).
The big pharma company Bristol Myers Squibb (BMS) has recruited contractmanufacturing and development organization (CDMO) Samsung Biologics to manufacture a commercial antibody cancer treatment until 2030.
Taiwan based contractmanufacturer, Bora Pharmaceuticals, in partnership with Taishin Healthcare Limited, is ready to spend millions to expand its footprint in the CDMO sector.
Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head business development at Novartis ContractManufacturing.
The filing with the FDA follows approval by several regulators across the world, including in the European Union and Japan. Under the terms of the agreement Pfizer will become one of several external partners who manufacture the investigational treatment for the disease.
Each month, Pharmaceutical Technology takes a look at recent decisions taken by regulatory and reimbursement agencies and identifies the key manufacturing players that can be impacted by them. Following similar decisions by the American and European regulators, Swissmedic approved Pfizer/BioNTech’s bivalent Comirnaty booster.
The South Korean player plans to expand its recently acquired US facility, provide contractmanufacturing services for Antibody Drug Conjugates (ADC), and to add drug product fill & finish facilities to establish a foothold in the North American CDMO market.
Three months ago, the FDA said it was unconvinced by a bridging study designed to show equivalence between Provention’s product intended for commercial sale, made by contractmanufacturer AGC Biologics, and the drug that teplizumab’s original developer Eli Lilly used in clinical trials.
This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster products. Several oncology products now have “blockbuster” status where sales exceed $1 billion annually.
CMOs are subject to cGMP regulations, so they have standard operating procedures they must follow. They also have multiple clients, and thus by definition have many demands on their time and resources, particularly their manufacturing equipment and analytical capabilities. Having a quality agreement in place is critical.
From automotive engineering firms retooling their operations to produce key components for ventilators to pharmaceutical manufacturers drastically ramping up production to meet unprecedented levels of demand, the agility of supply chains was key to overcoming the crisis. Government policy and regulation: Index score 6.96/10.
The US regulator has cleared both intravenous and subcutaneous formulations of Benlysta (belimumab) for the new indication, extending the use of the drug beyond its earlier label covering the treatment of active systemic lupus erythematosus (SLE) in combination with other medicines.
Amid incidents of toxic cough syrups, the organization has called on countries and regulators to strengthen action against the threat of substandard and falsified medical products.
Specifically, with some exceptions, parties that own or operate a facility engaged in the manufacturing or processing of a cosmetic product for distribution in the United States must list their facilities. In the case of contractmanufacturers, either the contractmanufacturer or the person whose name appears on the label (i.e.,
The problems outlined in the US regulator’s complete response letter (CRL) for VP-102 centre around contractmanufacturing organisation (CMO) Sterling Pharmaceuticals Services, which is producing VP-102 for Verrica. Sterling was classified by the FDA as voluntary action indicated (VAI) last November.
RNAi uses small RNA molecules to bind to messenger RNA, which is responsible for synthesising proteins, and either destroy it or recruit other cellular factors that regulate its activity. The nomination of a first candidate in the collaboration that will advance into development triggers a $2.5
Like all drugs, biologics are regulated by the FDA. In fact, most developers tend to rely on biologics contractmanufacturers / biologics contractmanufacturing for the development and production of low value / opportunity products, such as drugs for rare indications and biosimilars.
Pfizer-BioNTech COVID-19 vaccine; or regarding implicit unborn earnings from the contractmanufacturing agreement with BioNTech for the Pfizer-BioNTech COVID-19 vaccine. There can be no guarantee that our manufacturing of the the Pfizer-BioNTech COVID-19 vaccine will be successful.
The notice specified the two facility types: An OTC monograph drug facility is a foreign or domestic entity engaged in manufacturing or processing the finished dosage form of an OTC monograph drug. The Agency refers to such facility as a Monograph Drug Facility (MDF). The fee listed for MDFs was $14,060.
Now, the regulator has accepted the resubmission, kicking off another six-month review period as teplizumab has previously been awarded breakthrough status.
This demonstration process is strictly regulated by the Food and Drug Administration (FDA) in the US and the European Medicines Agency (EMA) in Europe. Once approved, these radioactive tracers are entitled as radiopharmaceuticals.
The US regulator has approved the anti-CD3 antibody as Tzield to delay the onset of stage 3 T1D in people eight years and older who currently have stage 2 disease, which according to the FDA “may provide patients with months to years without the burdens of disease.”
On Axsome’s second-quarter results call, chief executive Herriot Tabuteau said that the FDA letter received on 30 July indicated that the problems with the filing “preclude discussion of labelling and post-marketing requirements,” adding that the company has been in communication with the regulator to try to learn more.
Given that stem cell therapy manufacturing requires highly regulated, state-of-the-art technologies, it is difficult for stakeholders to establish in-house expertise for large-scale manufacturing of stem cell therapies.
Capacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by round 300 million doses a year, following an agreement to set up a new production line at contractmanufacturer Lonza. It is based on an inactivated SARS-CoV-2 virus, which has been killed and cannot cause COVID-19.
Four of the letters addressed failure to comply with drug Current Good Manufacturing Practice regulations, four more stated that the recipients were distributing unapproved drug products, two alleged violations of the Quality System Regulation by medical device manufacturers, and one was addressed to a clinical investigator.
The problems at the plant run by contractmanufacturer Emergent BioSolutions first emerged a few weeks ago, after an FDA inspection uncovered a string of violations including that the building was “not maintained in a clean and sanitary condition.” rather than three months if kept at 2-8 degrees Celsius.
Corticosteroids are produced by adrenal gland and play a role in controlling stress to decrease inflammation whereas, anabolic steroids regulate the manufacturing of testosterone in the testicles and the ovaries. This has led to an increased demand for contractmanufacturing service providers in this field.
The feeding strategy can be modified accordingly, in order to regulate cell growth and fermentation. In this type of culture, a growth-limiting substrate is fed during the process which extends the duration and density of the culture. As a result, the products are also removed continuously.
The feeding strategy can be modified accordingly, in order to regulate cell growth and fermentation. For instance, In March 2022, Mabion ordered four Kuhner Orbital Shaken Bioreactors (OSB) for contractmanufacturing of the first protein-based COVID 19 vaccine developed by Novavax.
Therma Bright is also in the process of identifying component suppliers to be used in the large-scale manufacturing of the SCV2 test and is identifying contractmanufacturers to manufacture and assemble the final product.
based contractmanufacturing business, Benuvia Manufacturing, which has significant chemistry and formulation capabilities, including manufacturing our FDA-approved cannabinoid drug, SYNDROS ® ,” said Todd C. and agonism of 5HT-1A, which regulate food intake, metabolism, weight control, and anxiety.
This demonstration process is strictly regulated by the Food and Drug Administration (FDA) in the US and the European Medicines Agency (EMA) in Europe. Once approved, these radioactive tracers are entitled as radiopharmaceuticals.
For over a decade, the company and its team have been leaders in the design, testing and manufacture of thin film drug formulations, particularly transdermal patches and sub-lingual (oral) strips for the delivery of active pharmaceutical ingredients (“API”) for the treatment of pain and neurological conditions.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content